Incretin-Based Glucose-Lowering Medications and the Risk for Acute Pancreatitis and/or Pancreatic Cancer Risk Reassuring Data from Cardio-Vascular Outcome Trials

Michael A Nauck, Juris J Meier and Wolfgang E Schmidt
Additional contact information
Wolfgang E Schmidt: Department of Medicine I, St. Josef-Hospital (Ruhr-University Bochum), Germany

Current Research in Diabetes & Obesity Journal, 2017, vol. 2, issue 3, 37-39

Abstract: Incretin-based medications (glucagon-like peptide-1 [GLP-1] receptor agonists and inhibitors of dipeptidyl peptidase-4 [DPP-4] are glucose-lowering drugs approved and introduced after [1]. Although both classes of drugs appeared to be relatively safe based on results from clinical trials and standard animal toxicology studies, epidemiological data [2,3] and histological findings [4] in genetically modified rodents exposed to such agents have raised concern that pancreatitis and pancreatic cancer may be long-term risks associated with this therapy.

Keywords: juniper publishers; diabetes journals; diabetes impact factor; endocrinology journal; endocrinology impact factor; endocrinology research journal; endocrinology research articles; diabetes open access journals; Obesity Journal; Diabetes & Obesity Journal (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/crdoj/pdf/CRDOJ.MS.ID.555586.pdf (application/pdf)
https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555586.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jcrdoj:v:2:y:2017:i:3:p:37-39

DOI: 10.19080/CRDOJ.2017.02.555586

Access Statistics for this article

Current Research in Diabetes & Obesity Journal is currently edited by Sophia Mathis

More articles in Current Research in Diabetes & Obesity Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().